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ABSTRACT  
 
BACKGROUND: Obstructive Sleep Apnea (OSA) is prevalent 
throughout the world.  However, there are currently limited data 
concerning the prevalence of OSA in populations that originate 
from developing countries; the prevalence of OSA is expected to 
rise in these countries.  OSA is poorly characterized amongst 
Ethiopians, and our study is the first to describe clinical 
characteristics of OSA among Ethiopians. 
METHODS: We conducted a retrospective study of primarily 
Ethiopian patients at an internal medicine clinic in Rockville, 
Maryland.  All patients (n=24) were evaluated for daytime 
sleepiness using the Epworth Sleepiness Scale (ESS) and received 
physical examinations and polysomnograms (PSG) by either 
portable monitoring (Itamar WatchPAT 200 device) or in-lab.  
Statistical analyses were performed in R. 
RESULTS: Linear regression model of Body-Mass Index (BMI) 
and Apnea-Hypopnea Index (AHI) indicated that for every 1-unit 
increase in BMI, there was a 0.8657-unit increase in AHI (p<0.05).  
Pearson’s correlation coefficient indicateda positive linear 
relationship between BMI and AHI (0.47) (p<0.05).   Adjusted 
linear regression model for AHI and oxygen saturation indicated 
that for every 1-unit increase of AHI, there was a 0.8452-unit 
decrease in nocturnal oxygen saturation (p<0.05).  Pearson’s 
correlation coefficient did not demonstrate significance between 
AHI and oxygen desaturation (p=0.062).  Patients received either 
continuous positive airway pressure (CPAP) (n=15) or oral 
appliance therapy (n=3). 
CONCLUSION: All patients who complied with therapy reported 
improved sleep quality, snoring resolution, and improved daytime 
alertness. Practitioners in developing countries should suspect 
OSA in the right clinical setting and offer diagnostic and 
therapeutic services when available. 
KEYWORDS: Apnea; Sleep Apnea, Obstructive; Ethiopia; 
Continuous Positive Airway Pressure; Sleep 
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INTRODUCTION  
 
Obstructive Sleep Apnea (OSA) is a highly 
prevalent disorder with known adverse 
cardiometabolic consequences (1).  Although OSA 
affects people in all parts of the world, there is 
little data on the state of the disorder in developing 
countries, particularly those in Africa.  
Appropriate diagnosis and management of OSA 
requires a trained and informed healthcare 
professional with access to diagnostic and 
therapeutic technology.  Currently, the delivery of 
sleep health services is non-existent in many 
developing countries.  The prevalence of OSA and 
its negative effects is expected to rise as society 
continues to change with urbanization, changes in 
lifestyle, and the rise of obesity worldwide.  The 
effect of untreated OSA on an individual 
significantly impacts quality of life and society at 
large.  It is urgent that medical professionals and 
the public in developing nations are informed 
about the disorder, its risk factors, and the 
diagnostic and therapeutic standards.   
In the last few years, many patients traveled 
from different parts of Africa for sleep medicine 
consultation services at a premier sleep disorders 
center in Rockville, Maryland, with people of 
Ethiopian descent representing the majority.  This 
study is the first to describe clinical and 
polysomnographic data in this special population.  
The objective of this article is to share our 
experience and raise awareness regarding OSA for 
practitioners in the developing world.   
 
MATERIALS AND METHODS 
 
We reviewed demographic, clinical, and 
laboratory data for Ethiopian patients who sought 
a sleep medicine consultation for possible sleep 
disorders of breathing between January 2014 and 
July 2017 at a premier sleep disorders center in 
Rockville, Maryland.  Electronic medical records 
of the Rockville Internal Medicine Group and 
Premier Sleep Disorders Center were our sources 
of clinical and polysomnographic data.  All 
patients had detailed sleep history and evaluation 
of daytime sleepiness by the Epworth sleepiness 
scale (ESS), a detailed physical examination, and 
a polysomnographic study.  Diagnostic and 
therapeutic sleep studies were done either by 
portable monitoring using the Itamar WatchPAT 
200 sleep diagnostic device or an in-lab 
polysomnographic study. 
Setting: Premier Sleep Disorders Center is an 
American Academy of Sleep Medicine accredited 
comprehensive sleep medicine center in Rockville, 
Maryland.  All patients were evaluated and 
followed by a board certified sleep medicine 
physician.  Pre- and post-diagnostic visits were 
made to discuss test results and therapeutic 
options.  Polysomnographic data was scored and 
reviewed according to the standard American 
Academy of Sleep Medicine diagnostic criteria by 
a board certified sleep technologist and a board 
certified sleep medicine physician.  The diagnosis 
of OSA was made using an apnea and hypopnea 
index of 5 and above in the setting of either 
daytime hypersomnia or other comorbidity (2). 
Continuous Positive Airway Pressure (CPAP) and 
Oral Appliance (OA) therapy were the main 
therapeutic interventions in addition to sleep 
hygiene and weight loss measures.  Patients who 
failed CPAP therapy were treated with oral 
appliance.  All patients had follow-up visits of 1-6 
weeks after initiation of therapy depending on 
their travel status. 
Statistical analysis: Statistical analyses of the 
association between Body-Mass Index (BMI) and 
the OSA Apnea-Hypopnea Index (AHI), as well as 
between AHI and nocturnal oxygen desaturation, 
were performed with the R package, version 3.4.2. 
Linear regression model was fitted for both sets of 
continuous variables and Pearson’s correlation 
coefficient was calculated for each relationship.  
OSA was modeled both as a continuous variable 
(AHI) and as an ordered categorical variable 
(apnea severity).  Apnea severity levels were 
defined as none (AHI = 1-4), mild (AHI = 5-15), 
moderate (AHI = 16-30), and severe (AHI > 30). 
 
RESULTS 
 
A total of 24 patients received sleep medicine 
consultation services for a suspected sleep 
disorder of breathing.  Descriptive characteristics 
of the sample population are shown in Table 1.  
The group was predominantly male (79.1%) with 
an average age of 53.9 (range: 32-76) and an 
average BMI of 29.5 (range: 18.6-40.1).  
According to CDC standards for BMI 
classification, 41.7% of the subjects were 
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overweight and another 41.7% were obese or 
morbidly obese (3). While all patients were of 
Ethiopian descent, the majority (54.2%) traveled 
from Ethiopia seeking medical care due to a 
paucity of sleep medicine services in Ethiopia. 
The rest (45.8%) were permanent residents of the 
United States. 
All patients underwent a sleep study either by 
portable sleep monitoring (70.8%) or in-lab 
polysomnography (29.2%) for diagnosis; 21 
patients met the diagnostic criteria for OSA with 
an overall prevalence rate of 87.5%.  Presenting 
symptoms included un-refreshing sleep (100%), 
fatigue (95.8%), snoring (95.8%), daytime 
hypersomnia given an ESS > 8 (79.1%), witnessed 
apnea (58.3%), and headache (33.3%).  Among 
the 21 patients with OSA defined by an AHI of 5 
or greater, only 9 (42.9%) had a BMI greater than 
30.   
 
Table 1: Patient demographics 
 
Characteristic Category Number (percent) 
Gender Male 19(79.1) 
 Female 5(20.8) 
Age Mean (25% - 75%) 53.9(46.5 - 62.5) 
 Range 32-76 
Country of Residence Ethiopia 13(54.2) 
 United States 11(45.8) 
BMI (kg/m2) Mean (25% - 75%) 29.5(26.1 - 33.3) 
 Range 18.6 - 40.1 
Symptoms Snoring 23(95.8) 
 Un-refreshing sleep 24(100) 
 Witnessed apnea 14(58.3) 
 Fatigue 23(95.8) 
 Headache 8(33.3) 
 ESS > 8 19(79.1) 
Comorbidities Diabetes mellitus 6(25) 
 Hypertension 13(54.2) 
Diagnostic evaluation PSG 7(29.2) 
 Home study 17(70.8) 
Degree of Apnea None 3(12.5) 
 Mild  12(50) 
 Moderate  6(25) 
 Severe  3(12.5) 
 
Linear regression model was run to test the 
association between BMI and AHI as continuous 
variables (Table 2).  The initial model included 
age and gender as possible covariates, but neither 
was significant.  Tested separately, neither age nor 
gender showed any suggestion of an association 
with AHI.  The final model included only BMI as 
an independent variable.  The linear regression  
 
 
 
model demonstrated that for every increase of 1 
unit in BMI, there was an expected increase of 
0.8657 units in AHI (p-value < 0.05).  
Furthermore, there was a moderate positive linear 
relationship between BMI and AHI as quantified 
by Pearson’s correlation coefficient of 0.47 (p-
value < 0.05).  Although the association was 
significant, it did not explain a large portion of the 
variance in AHI, as can be seen in Figure 1A. 
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Table 2: Linear regression for BMI and AHI 
 
 Dependent variable 
 AHI 
O2 Sat 0.866** 
 (0.348) 
Constant -10.574* 
 (10.438) 
Observations 24 
R2 0.220 
Adjusted R2 0.184 
Residual Std.  Error 9.231 (df = 22) 
F Statistic 6.199** (df = 1; 22) 
Note                                                                                           p<0.05 
 
            
 
Figure 1A: Scatterplot with trendline for apnea-hypopnea index (AHI) versus body-mass index (BMI); 
Figure 1B: Scatterplot with trendline for O2 saturation versus apnea-hypopnea index (AHI) 
 
A separate linear regression model was run to test 
the association between AHI and oxygen 
saturation level as continuous variables.  Initially 
there was not a significant association between 
oxygen saturation and AHI (Table 3, p-value > 
0.05).  However, excluding a single outlier for 
whom the data demonstrated a maximum 
desaturation to 62%, an adjusted linear regression 
showed that for every increase in one unit of AHI, 
there was a 0.8452 unit decrease in nocturnal 
oxygen saturation (Table 4, p-value < 0.05).  The 
Pearson’s correlation coefficient for 23 subjects, 
excluding the aforementioned outlier, 
demonstrated an almost significant moderate 
negative linear association between AHI and 
oxygen desaturation (p-value = 0.062). Although 
the trend was in the right direction, that is, the 
estimate was in the negative direction, again, the 
actual values of AHI varied greatly from the 
model’s predicted values (Figure 1B). 
Classification of sleep apnea by severity did not 
yield any significant associations between severity 
and either BMI or oxygen saturation (analyses not 
shown).   
 
Table 3: Linear Regression for O2 saturation  
and AHI with outliers 
 Dependent variable 
 AHI 
O2 Sat -0.334 
 (0.294) 
Constant 43.546* 
 (25.240) 
Observations 24 
R2 0.055 
Adjusted R2 0.012 
Residual Std.  Error 10.157 (df = 22) 
F Statistic 1.289 (df = 1; 22) 
Note            p<0.05 
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CPAP was elected as a first line therapy in 15 
patients, while oral appliance therapy was used as 
first line in 3 patients.  Among patients who were 
elected for CPAP, 4 failed CPAP and 3 of those 
patients followed with oral appliance therapy.  
Three patients declined therapy.   
CPAP therapy was initiated after in-lab 
polysomnographic pap titration or using auto 
CPAP.  FDA-approved prefabricated or custom 
oral appliances were used when considering oral 
appliance therapy.  As most patients were paying 
out of pocket, economic factors affected the 
decisions made for both diagnostic and therapeutic 
methods of intervention.   
At follow-up, all patients who complied with 
either CPAP or oral appliance therapy reported 
improved sleep quality, resolution of snoring, and 
improved daytime alertness.  Long-term follow-up 
was not possible as the majority of the patients 
resided in Ethiopia.  The longest follow-up was 
done for patients residing in the United States.  
The overall success of therapy was impressive. 
 
Table 4: Linear Regression for O2 saturation and 
AHI without outliers. 
 Dependent variable 
 AHI 
O2 Sat -0.845** 
 (0.387) 
Constant 88.337** 
 (33.547) 
Observations 23 
R2 0.185 
Adjusted R2 0.146 
Residual Std.  Error 9.604 (df = 21) 
F Statistic 4.769** (df = 1; 21) 
Note                            p<0.05 
 
DISCUSSION 
 
OSA is a highly prevalent and under-diagnosed 
medical condition.  In the developed world, 
including the United States of America, only 20% of 
patients are diagnosed and treated (4). In Africa, 
with a rapidly growing population of over one 
billion, the delivery of sleep medicine services is at 
its embryonic stage.  Excluding Southern Africa, few 
countries in the continent have started incorporation 
of sleep medicine into the healthcare system.  Egypt, 
Nigeria, Morocco, and Tunisia are a few African 
countries that are taking the lead (5-9). Lack of 
knowledge about sleep and its disorders, lack of 
trained personnel, the high level of capital needed to 
establish sleep medicine services, and the 
unavailability of diagnostic centers and therapeutic 
devices are believed to be some of the reasons for 
Africa’s lag in incorporating sleep medicine into its 
patient services.  Studies conducted among 
graduating medical students in Nigeria found that 
only 41% of the students were confident in 
recognizing signs and symptoms suggestive of OSA 
(10). For the above reasons, the state of OSA in 
African countries, including its prevalence, clinical 
presentations, clinical consequences, and interactions 
with other comorbid medical conditions, is largely 
unknown. 
Nonetheless, a few preliminary studies indicate 
that it is a highly prevalent medical condition.  A 
study among Nigerian young adults found a 19% 
(22% males, 16% females) prevalence of clinical 
OSA (study conducted using a validated 
questionnaire) (5). In Ethiopia, 19% of college 
students were found to have high risk for clinical 
OSA (11). A study in Egypt found a prevalence of 
42% among children with epilepsy, with an 
observation that OSA contributed to seizure 
frequency (6).  Nigerian adult hypertensives were 
found to have a 52% prevalence of clinical sleep 
apnea while patients with type II diabetes mellitus 
had a 27% prevalence in the same population (7,8). 
In Morocco, among patients seen for pulmonary 
consultation at a tertiary medical center, a 56.7% 
prevalence of OSA was observed (9). These 
preliminary studies indicate that the burden of OSA 
in Africa is high.  Additionally, some of the above 
studies identified obesity (high BMI and large neck 
size) as risk factors.  However, detailed clinical 
descriptions of subjects, objective diagnostic testing 
supported by polysomnographic monitoring, severity 
of disease classification, and management strategies 
have not been discussed in the few studies published 
on OSA among Africans. 
Ethiopia, Africa’s second most populous nation 
with a population above 90 million in the midst of 
demographic transformation, has just started 
implementing diagnostic sleep medicine services.  
Our study is the first to describe clinical 
characteristics of OSA among Ethiopians.  The 
confirmation of the diagnosis with objective 
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polysomnographic testing is one strength of our 
observations.  We found all spectrums of the disease, 
including mild, moderate and severe OSA, in our 
cohort.  BMI correlated as a risk factor for increased 
AHI in our series (p < 0.05), although the association 
explained only a small part of the variance in AHI, 
as demonstrated in Figure 1A, where actual values of 
AHI were widely dispersed above and below the 
model’s predicted values.  We also found that there 
was a significant nocturnal oxygen arterial 
desaturation at the mild and moderate stages of the 
disease.  A linear model testing the association 
between AHI and oxygen saturation was significant 
only with the exclusion of a single outlier.  Again, as 
shown in Figure 1B, there was a wide dispersion and 
variance in values from the predicted value line in 
the model.  Nonetheless, this is a critical observation 
as craniofacial features may play a significant role in 
the causation of the diseases among Ethiopians, in 
addition to obesity.  It also suggests that Ethiopians 
may suffer serious consequences of the disease even 
in its milder forms, as they exhibit significant 
intermittent nocturnal hypoxia.  This has been 
suspected among African Americans in the United 
States.   
We understand that due to the small size of the 
study population and because it represents a highly 
selected patient population who had access to a 
specialized service in the United States, the findings 
from this study may not be directly translatable to 
the general public of Ethiopia.  Despite this 
limitation, we can conclude that this is the first study 
reporting on a very important clinical syndrome 
among Ethiopians that may have far-reaching 
consequences.  The authors call on the attention of 
practitioners in developing countries to suspect OSA 
in the right clinical setting and offer a diagnostic and 
therapeutic service when available. 
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